These four names in particular have made some stunning moves.
Santarus gets a cash infusion from Visium Asset Management.
Take advantage of a pullback to pick up a high-quality stock at a great price.
Plenty of leadership remains in the health care sector and there’s reason to see further potential.
Deep-in-the-money call options on these five names could provide a healthy return.
Occasionally there is unusual technical synchronization on multiple timeframes.
The stock is leaving behind this short-term base.
Keep this one on the radar for a pullback buying opportunity.
Feeling good about the biotechs.
Charts of Actavis and Alexion show a combination of positive technical factors.
Co misses on revenues. Revenue rose (if you can call it that) 0.8% to $1.7 bin. (I was looking for 1.7% y/y rev growth.)...
We added a call spread for NTAP here, not as pricey as the move implies, the chart not looking too bad. I like this for...
Real Money Pro Quick Links
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data
. Company fundamental data provided by Morningstar
. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.
TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.
IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.